Polydextrose
Synthetic glucose-polymer fiber — high tolerance (50 g/day), low FODMAP, moderate bifidogenic effect.
Polydextrose in 1 minute
What does it provide? A synthetic, partially branched glucose polymer (average DP 12) produced from glucose, sorbitol, and citric acid by heat-catalyzed polymerization (Pfizer 1981 patent). Minimally absorbed in the small intestine, slowly and partially fermented in the colon — moderate bifidogenic effect with low gas profile. Outstanding tolerance: 50 g/day acute dose well tolerated in adults (the highest tolerance threshold among commercial fiber supplements). Caloric content: 1 kcal/g (food-industry standard).
How much? Functional food additive: 4–12 g/serving. Standalone supplement: 8–12 g/day starting range, acute tolerance up to 50 g/day. Bifidogenic effect in human RCTs at 8–12 g/day was the typical dose (Costabile 2012 Br J Nutr).
When to avoid? Severe sorbitol intolerance (small sorbitol residue may remain from production), severe fructose malabsorption (sorbitol cross-reactivity), active UC/Crohn's flare (relative caution), strong soluble-fiber sensitivity (rare), very high acute dose (> 50–90 g at once — osmotic diarrhea threshold).
Polydextrose was patented in 1981 by Pfizer (Rennhard patent, with US Patent 3,766,165 as precursor) as a carbohydrate-replacing, low-calorie bulking agent. The process: D-glucose (about 90%), sorbitol (about 10%), and catalytic amounts of citric acid are heated under vacuum — the product is a branched, randomly polymerized glucose mixture (DP 2–120, average DP 12). Polydextrose was originally introduced as a sugar substitute in dietary products (light sodas, light biscuits, sugar-free chocolates).
The FDA recognized it in 1981 (21 CFR 172.841), and the EU approved it in 1986 (as additive E1200). In the 2000s, the scientific community rediscovered its fiber function: Hengst 2009 Int J Food Sci Nutr RCT demonstrated bifidogenic effect, Jie 2000 AJCN and Forssten 2014 Int J Food Sci Nutr documented SCFA production and lipid modulation. The FDA formally recognized it as "dietary fiber" in 2016 in the new Nutrition Facts panel regulation (21 CFR 101.9); EFSA 2017 (E 1200 re-evaluation) reaffirmed the safety profile. Today polydextrose is one of the global food industry's main functional fiber additives — particularly as performance enhancer in baked goods, yogurts, "high-fiber" snacks, and "low-calorie" beverages.
Scientific Background
Polydextrose is a synthetic, soluble, partially branched glucose polymer with average degree of polymerization (DP) ≈ 12 (distribution DP 2–120). During production, glucose forms a randomly branched (α-1,6, α-1,2, α-1,3, β-1,6) polymer matrix — so human digestive enzymes (amylase, glucosidases) essentially do NOT break it down. The remainder (1–2%) sorbitol and citric acid stays as end-chain capping groups. Colonic fermentation is slow and PARTIAL (≈ 50–60% colonic fermentation, ≈ 30% excreted unchanged in feces), resulting in a mild gas profile and exceptionally high tolerance.
Caloric content — standardized value. The official caloric content of polydextrose is 1 kcal/g (FDA, EFSA, Codex Alimentarius — accounting for partial fermentation and minor carbohydrate absorption). This is ¼ of normal carbohydrate (4 kcal/g) energy — hence "low-calorie bulking agent."
Microbiome effect — RCT evidence. Costabile A et al. Br J Nutr 2012;108(3):471–481 (double-blind, crossover, placebo-controlled feeding study) in healthy adults: 8 g/day polydextrose for 21 days significantly raised Bifidobacterium and reduced Bacteroides proportion. Hengst C et al. Int J Food Sci Nutr 2009;60(Suppl 5):96–105 and Forssten 2014 Int J Food Sci Nutr in additional RCTs showed similar bifidogenic effect and elevated fecal SCFA production. The bifidogenic effect is MODERATE (smaller than FOS/inulin), BUT GI tolerance is SUBSTANTIALLY HIGHER.
GI tolerance — outstanding. Flood MT, Auerbach MH, Craig SAS. Food Chem Toxicol 2004;42(9):1531–1542 review of clinical tolerance studies of polydextrose: healthy adults tolerated 50 g/day acute dose without uncomfortable symptoms. The typical laxative threshold (osmotic diarrhea) is around 90 g/day — EXTREMELY high, well above FOS (15 g) or inulin (20 g) thresholds.
Glycemia and body weight. Polydextrose glycemic index ≈ 7 (essentially 0). Konig 2012 Nutr J premeal polydextrose supplement (12 g) reduced postprandial glucose peak. Astbury NM et al. Br J Nutr 2014;111(8):1499–1505 RCT showed premeal polydextrose dose-dependently reduced the next ad libitum meal's energy intake — small satiety-enhancing effect.
Lipid profile. Jie 2000 AJCN RCT in hypercholesterolemic patients: 12 g/day polydextrose for 4 weeks produced mild LDL reduction. Effect size smaller than oat beta-glucan or psyllium — moderate.
FODMAP status. Monash low FODMAP — well tolerated in IBS at normal dietary doses. High dose (> 30 g/day), however, can trigger osmotic effect.
Regulatory status. FDA: 21 CFR 172.841 (additive), 21 CFR 101.9 (dietary fiber recognition, 2016). EU: E1200 additive (1986); EFSA ANS Panel "Re-evaluation of polydextrose (E 1200) as a food additive." EFSA Journal 2017;15(1):4544 reaffirmed the safety profile and fiber classification. Codex Alimentarius: recognized fiber.
- + Functional yogurt, smoothie, coffee: taste-neutral, mixable soluble powder.
- + Other soluble fibers (psyllium, beta-glucan): broader SCFA profile.
- + Sugar substitution in diet baked goods: industry kitchen standard.
- + 15–30 minutes before a meal: satiety enhancement (Saetner 2010).
- + IBS low FODMAP diet (Monash): accepted fiber replacement.
- + Ample fluid: general fiber rule.
- High-dose sorbitol-containing foods (sugar-free gum, polyol mix) simultaneously: cumulative osmotic load.
- Abrupt start at 30+ g/day without titration: mild osmotic diarrhea.
- Other high-FODMAP fiber at high doses simultaneously (FOS + GOS + polydextrose): cumulative fermentation, although polydextrose is low FODMAP.
- Large dose (> 50 g acute) of "sugar-free" sweets with polydextrose: diarrhea threshold.
- "Fiber blend" with sugar additive: worsens metabolic profile.
- Severe sorbitol intolerance: due to small sorbitol residue.
- Severe fructose malabsorption: sorbitol cross-reactivity.
- Active UC/Crohn's flare: relative caution (generally tolerated, but medical judgment).
- Severe dysphagia: powder dissolves rapidly — lower choking risk than psyllium.
- Infants < 1 year: no established safety data.
- Severe renal failure: generally fine, moderate dose.
- Recent bowel surgery: medical clearance.
- Very high acute dose (> 50 g): osmotic diarrhea threshold is individual.
- Acute abdominal complaints of unknown cause: avoid until workup.
References
[1] Costabile A et al. Impact of polydextrose on the faecal microbiota: a double-blind, crossover, placebo-controlled feeding study in healthy human subjects. Br J Nutr 2012;108(3):471–481. Link
[2] Hengst C et al. Effects of polydextrose supplementation on intestinal microbiota and short-chain fatty acid production in healthy adults. Int J Food Sci Nutr 2009;60(Suppl 5):96–105. Link
[3] Forssten SD et al. Influence of a probiotic combination on faecal bifidobacteria — polydextrose effect. Int J Food Sci Nutr 2014. Link
[4] Flood MT, Auerbach MH, Craig SAS. A review of the clinical toleration studies of polydextrose in food. Food Chem Toxicol 2004;42(9):1531–1542. Link
[5] Jie Z et al. Studies on the effects of polydextrose intake on physiologic functions in Chinese people. Am J Clin Nutr 2000;72(6):1503–1509. Link
[6] Konig D et al. Polydextrose and reduction in postprandial glycaemic response. Nutr J 2012.
[7] Astbury NM et al. Polydextrose results in a dose-dependent reduction in ad libitum energy intake at a subsequent test meal. Br J Nutr 2014;111(8):1499–1505. Link
[8] EFSA ANS Panel. Re-evaluation of polydextrose (E 1200) as a food additive. EFSA Journal 2017;15(1):4544. Link
[9] FDA. 21 CFR 172.841 (food additive) + 21 CFR 101.9 (dietary fiber recognition, 2016). Link